Soccertese
I'm confused. I thought the only continuous levodopa delivery method of treatment was Duodopa, a gel paste delivered directly into the duodenum bypassing the stomach via a pump ( much like an insulin pump). I am assuming this gel does not need carbidopa since nausea should not be an issue. Duodopa has been approved and used successfully in Europe for several years.

This article describes another product in the pipeline - one of which I was unfamiliar. This appears to be levodopa in liquid? form but delivered with a patch/pump subcutaneously. And this treatment contains carbidopa. I wonder where this pump is worn ( on what part of the body) that requires the addition of carbidopa. This one has just entered phase II following a successful phase I, which is the safety phase.

Does anyone have a contact for the latter treatment? It's called NDO612 (I think!)
Peggy


Or am I just super mixed up about this???